Transdermal (TDS) Oxybutynin (Oxytrol(r)) in Overactive Bladder

Clinical trial NCT00224146 · COMPLETED

Trial details

NCT number: NCT00224146
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Overactive Bladder Urinary Incontinence Quality of Life

Start date: 2004-05-01
Primary completion: 2005-05-01
Enrollment: 2878

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.